InvestorsHub Logo

$5.95akadawson-m

06/30/20 7:46 PM

#89314 RE: MO_Hacker #89295

I'm sure most have seen this now:

SEC 'must immediately' halt 'promotion scheme' CytoDyn, Citron Research says Citron Research said in a short report published on its website that the SEC "must immediately halt" CytoDyn, adding that "we cannot remember the last time we've seen a bigger joke of a stock." The "stock promotion scheme" claims to have the cure for COVID "with zero data," according to Citron, which claims that the company "has issued 51 press releases, conducted 5 conference calls, participated in no less than 24 interviews, and has utilized several thirdparty investor relations and stock newsletter services" in order to "aggressively" tout its investigational drug candidate, Leronlimab, as a potential treatment for COVID-19. Reference Link

Read more at:
https://thefly.com/landingPageNews.php?id=3118988